bioMérieux Balance Sheet Health
Financial Health criteria checks 6/6
bioMérieux has a total shareholder equity of €3.9B and total debt of €393.6M, which brings its debt-to-equity ratio to 10.1%. Its total assets and total liabilities are €5.3B and €1.4B respectively. bioMérieux's EBIT is €586.5M making its interest coverage ratio 217.2. It has cash and short-term investments of €272.2M.
Key information
10.1%
Debt to equity ratio
€393.60m
Debt
| Interest coverage ratio | 217.2x |
| Cash | €272.20m |
| Equity | €3.88b |
| Total liabilities | €1.44b |
| Total assets | €5.32b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: EYWN's short term assets (€2.2B) exceed its short term liabilities (€1.0B).
Long Term Liabilities: EYWN's short term assets (€2.2B) exceed its long term liabilities (€437.8M).
Debt to Equity History and Analysis
Debt Level: EYWN's net debt to equity ratio (3.1%) is considered satisfactory.
Reducing Debt: EYWN's debt to equity ratio has reduced from 25.4% to 10.1% over the past 5 years.
Debt Coverage: EYWN's debt is well covered by operating cash flow (125.7%).
Interest Coverage: EYWN's interest payments on its debt are well covered by EBIT (217.2x coverage).